Crossmark

Validation of the Thai version of the family reported outcome measure (FROM-16)© to assess the impact of disease on the partner or family members of patients with cancer

Crossref DOI link: https://doi.org/10.1186/s12955-019-1091-3

Published Online: 2019-02-08

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chantarasap, Pattariya

Johns, Nutjaree Pratheepawanit

Pairojkul, Srivieng

Sookprasert, Aumkhae

Wirasorn, Kosin

Cheawchanwattana, Areewan

Salek, Sam

Subongkot, Suphat http://orcid.org/0000-0002-0013-2252
Funding

Funding for this research was provided by:

Faculty of Pharmaceutical Sciences, Khon Kaen University, Thailand (1/2558)
License Information

Text and Data Mining valid from 2019-02-08
More Information

Article History

Received: 17 March 2018

Accepted: 14 January 2019

First Online: 8 February 2019

Ethics approval and consent to participate

: The study protocol was approved by Khon Kaen University Ethics Committee in human research, record number 4.2.05:43/2015. Written informed consent was obtained from both family members and patients prior to data collection.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below